CLINICAL_TRIALS
trial_result
· 2019-07-24
Clinical Trial Update: A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants [Phase 4]
Summary
Phase 4 trial assessing safety and efficacy of leuprorelin in Chinese participants with central precocious puberty has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Central Precocious Puberty | Phase 4 | Status: COMPLETED | Results posted: 2019-07-24